MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.
On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.
advertisement
One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars
Next article： Drug repurposing or repositioning? The language matters
Next article： Drug repurposing or repositioning? The language matters
